NCT07357818 Effects of Caffeinated Beverages on Well-being
| NCT ID | NCT07357818 |
| Status | Recruiting |
| Phase | — |
| Sponsor | GUAYAKI SUSTAINABLE RAINFOREST PRODUCTS, INC. |
| Condition | Healthy |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2025-11-03 |
| Primary Completion | 2026-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2025-11-03 with a primary completion date of 2026-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will evaluate post-beverage subjective caffeine responses and physiological responses to caffeinated beverages in generally healthy adults.
Eligibility Criteria
Inclusion Criteria: 1. Males or females, ≥18 to ≤55 years of age 2. BMI ≥18.5 and \<29.9 kg/m2 3. Generally good health 4. Participant currently and consistently has a caffeine routine 5. Participant is willing to substitute their current caffeine routine for the test beverage daily 6. Participant has never consumed the test beverage or similar products 7. Participant currently owns a wearable and is willing to use and connect the wearable device 8. Willing to use personal smart phone, tablet, or personal computer with stable internet connection 9. Willing and able to comply with all study procedures 10. Willing to adhere to all study procedures, including lifestyle considerations and sign forms providing informed consent to participate in the study Exclusion Criteria: 1. History or presence, on the basis of the health history, of clinically important condition or disease states 2. Is currently following, or planning to be on, a weight loss regimen 3. Weight loss or gain \>4.5 kg 4. History of gastrointestinal surgery for weight reducing purposes or gastrointestinal (GI) conditions 5. History of an eating disorder (e.g., anorexia nervosa or bulimia nervosa, binge eating) at the discretion of the Clinical Investigator. 6. History of unconventional sleep patterns (e.g., night shift) or diagnosed sleep disorder 7. Use of tobacco/nicotine products 8. Use of hemp/marijuana products 9. Unstable use of any prescription medication 10. Use of any medications(s) or dietary supplement(s), containing caffeine, or interacting with caffeine 11. Recent history of alcohol or substance abuse 12. Exposed to any non-registered drug product 13. Self-report of hypertension/high blood pressure without use of hypertensive medications 14. Any known allergy or intolerance to any ingredients contained in the study product 15. Any signs or symptoms of active infection of clinical relevance 16. History or presence of cancer, except for non-melanoma skin cancer 17. History of any major trauma or major surgical event 18. Female who is pregnant, planning to be pregnant during the study period, lactating 19. An employee, close relative of an employee, or participant who has a financial interest in Sponsor company or any other caffeine beverage company. 20. Any condition the Investigator believes would interfere with the participant's ability to provide informed consent or comply with the study protocol 21. A clinically significant medical condition that is affected by caffeine
Contact & Investigator
Kristin Nieman, PhD
PRINCIPAL INVESTIGATOR
Nlumn LLC
Frequently Asked Questions
Who can join the NCT07357818 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 55 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07357818 currently recruiting?
Yes, NCT07357818 is actively recruiting participants. Contact the research team at info@guayaki.com for enrollment information.
Where is the NCT07357818 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT07357818 clinical trial?
NCT07357818 is sponsored by GUAYAKI SUSTAINABLE RAINFOREST PRODUCTS, INC.. The principal investigator is Kristin Nieman, PhD at Nlumn LLC. The trial plans to enroll 150 participants.